@zapca77: #calanaka

zapca🇸🇴

Open In TikTok:

Region: SO

Thursday 25 June 2026 18:52:29 GMT

679

89

1

7

Music

Download

No Watermark .mp4 (1.38MB) No Watermark(HD) .mp4 (1.38MB) Watermark .mp4 (4.24MB) Music .mp3

Comments

XIIN KA JIKTORKA :

🥰🥰🥰

2026-06-25 23:00:17

0

To see more videos from user @zapca77, please go to the Tikwm homepage.

Other Videos

#fyp #viral

This modified compound is known as JRT, developed by researchers at Delix Therapeutics and the University of California, Davis. By replacing specific atoms in LSD’s structure, they created a molecule that retains therapeutic properties but significantly reduces or eliminates hallucinogenic effects. JRT acts as a serotonin receptor modulator and has shown antidepressant-like and pro-cognitive effects in animal studies, making it a promising candidate for treating conditions like schizophrenia and depression. Another related compound is SPT-348, a prodrug of 2-bromo-LSD (also known as BOL-148). SPT-348 is designed to bypass first-pass metabolism in the liver, enhancing its therapeutic potential. Like JRT, it aims to provide the mental health benefits associated with psychedelics without inducing hallucinations. These developments represent a significant step in creating next-generation psychoplastogens—compounds that promote neural plasticity—offering new avenues for mental health treatments without the side effects commonly associated with traditional psychedelics. Follow us 👉 @sciencefunn for more science and daily facts.🤓 Enjoy the rest of your day.😇

This modified compound is known as JRT, developed by researchers at Delix Therapeutics and the University of California, Davis. By replacing specific atoms in LSD’s structure, they created a molecule that retains therapeutic properties but significantly reduces or eliminates hallucinogenic effects. JRT acts as a serotonin receptor modulator and has shown antidepressant-like and pro-cognitive effects in animal studies, making it a promising candidate for treating conditions like schizophrenia and depression. Another related compound is SPT-348, a prodrug of 2-bromo-LSD (also known as BOL-148). SPT-348 is designed to bypass first-pass metabolism in the liver, enhancing its therapeutic potential. Like JRT, it aims to provide the mental health benefits associated with psychedelics without inducing hallucinations. These developments represent a significant step in creating next-generation psychoplastogens—compounds that promote neural plasticity—offering new avenues for mental health treatments without the side effects commonly associated with traditional psychedelics. Follow us 👉 @sciencefunn for more science and daily facts.🤓 Enjoy the rest of your day.😇

new kini

Now available rx350 2015 on belt 24.5M DIRECT TOKS 🇺🇸 #fyppppppppppppppppppppppp

Now available rx350 2015 on belt 24.5M DIRECT TOKS 🇺🇸 #fyppppppppppppppppppppppp

first day of school!!

first day of school!!

About

Robot
API

Legal

Privacy Policy